Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Collaborative agreement on exablate neuro technology

InSightec : 26 August, 2016  (Company News)
Insightec and Siemens have signed an agreement on the the development of integrated MRI and exablate neuro technology
Collaborative agreement on exablate neuro technology

Insightec, a provder of MR-guided Focused Ultrasound (MRgFUS) therapy equipment, has announced the signing of a strategic Siemens. The strategic collaboration will involve the development of compatibility between Exablate Neuro and Siemens 1.5T and 3T clinical MRI systems, MAGNETOM Aera and Skyra. With this agreement, Siemens follows its strategy of broadening and complementing its diagnostic imaging portfolio with advanced therapy products. Both parties will work towards providing access to Exablate Neuro for installed base, as well as new product installation customers.



Exablate Neuro is the world’s first and only CE and FDA-approved device for the non-invasive application of MR guided focused ultrasound to treat essential tremor and other conditions. Clinical research, development and regulatory approvals are ongoing for additional neurosurgical applications and markets.



“Our agreement with Siemens will allow us to significantly expand Exablate Neuro’s market presence. Siemens has embraced our technology and together we will bring our therapy to significantly more patients and providers,” said Maurice Ferré MD, Insightec Chief Executive Officer and Chairman of the Board. “Insightec is committed to continue investing in research and development of MRgFUS technology. The strategic collaboration with Siemens will allow more patients and researchers globally to benefit from the unique MRgFUS technology,” he concluded.



Christoph Zindel, MD, Senior Vice President and General Manager of Siemens’ Magnetic Resonance business further highlights the importance of the agreement: “This strategic partnership of two major organisations is exciting and further underlines Siemens’ strategy of enabling better patient outcomes by broadening its diagnostic imaging portfolio into advanced therapies in the area of neurological and other disorders. Together with Insightec and its innovative technology, we will jointly drive healthcare further together with our strong research and clinical customer network worldwide.”



Exablate Neuro uses focused ultrasound waves to precisely target and accurately ablate tissue deep within the brain with no incisions, and while minimising damage to adjacent healthy tissue. Siemens MR imaging plans to provide patient-specific treatment planning and continuous temperature monitoring for assessing treatment outcome in real-time during Exablate Neuro procedures.


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo